Lack of Efficacy of Tacrolimus in the Treatment of Vitiligo in the Absence of UV-B Exposure

Segmental vitiligo: A randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream

“…[11] In this study, no statistically significant correlation could be made between the response to treatment and the site of involvement, disease progression or duration of disease in either group.…”

Response of vitiligo to once‐ vs. twice‐daily topical tacrolimus: a controlled prospective, randomized, observer‐blinded trial

“…Previous studies on tacrolimus for vitiligo have provided conflicting results 5–9,12,13 . A double‐blind randomized study compared 0.1% tacrolimus with 0.05% clobetasol in 20 Mexican children.…”

Awareness of Generational Differences Is the First Step

“…Initial laboratory findings were as follows: platelet count, 70ϫ10 3 During the following days, the newborn developed leukocytosis (white blood cell count, 17.1ϫ10 3 /µL), and his C-reactive protein level increased to 13.79 mg/L.…”

“…5,6 We wanted to treat only areas covered by clothes to be sure that they would be protected from the sun, 3 and so most of the lesions were located in very resistant parts of the body. 5,6 We wanted to treat only areas covered by clothes to be sure that they would be protected from the sun, 3 and so most of the lesions were located in very resistant parts of the body.…”